Cintia Piccina
Fortuna: 3 999 $ al 30/06/2026
Fortuna: 3 999 $ al 30/06/2026
Cintia Piccina is currently Chief Commercial Officer at Autolus Therapeutics Plc since 2025.
Former roles include Chief Commercial Officer at Adaptimmune Therapeutics Plc from 2022 to 2023, Chief Commercial Officer at AlloVir, Inc. from 2023 to 2024, SVP-Commercial Oncology & US General Manager at 2seventy Bio, Inc. from 2021 to 2022, and Vice President-Oncology at Novartis Pharmaceuticals Corp.
from 1997 to 2020.
Education includes a doctorate from the University of Sao Paulo and an MBA from Escola Superior de Propaganda e Marketing.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/04/2025 | 666.438 ( 0,04 % ) | 3 999 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 01/09/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| ALLOVIRPAR | Corporate Officer/Principal | 01/03/2024 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | 01/02/2022 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/04/2020 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Sao Paulo
University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escola Superior de Propaganda e Marketing
Escola Superior de Propaganda e Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
2seventy Bio, Inc.
2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.